Fidelis Capital Partners LLC Purchases 12,283 Shares of Oracle Corporation $ORCL

Fidelis Capital Partners LLC lifted its position in shares of Oracle Corporation (NYSE:ORCL) by 64.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 31,439 shares of the enterprise software provider’s stock after purchasing an additional 12,283 shares during the quarter. Oracle makes up about 0.7% of Fidelis Capital Partners LLC’s investment portfolio, making the stock its 29th largest position. Fidelis Capital Partners LLC’s holdings in Oracle were worth $8,842,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Brighton Jones LLC raised its stake in shares of Oracle by 189.3% in the 4th quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider’s stock valued at $25,593,000 after buying an additional 100,494 shares in the last quarter. Revolve Wealth Partners LLC increased its stake in Oracle by 8.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider’s stock valued at $903,000 after acquiring an additional 404 shares during the period. Sivia Capital Partners LLC increased its stake in Oracle by 21.5% in the second quarter. Sivia Capital Partners LLC now owns 4,348 shares of the enterprise software provider’s stock valued at $951,000 after acquiring an additional 768 shares during the period. Wetzel Investment Advisors Inc. acquired a new position in Oracle in the second quarter worth about $202,000. Finally, O ROURKE & COMPANY Inc bought a new position in Oracle during the second quarter worth about $212,000. 42.44% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Oracle

In other Oracle news, insider Mark Hura sold 15,000 shares of the business’s stock in a transaction dated Wednesday, December 24th. The stock was sold at an average price of $196.89, for a total transaction of $2,953,350.00. Following the completion of the sale, the insider directly owned 234,077 shares of the company’s stock, valued at approximately $46,087,420.53. The trade was a 6.02% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Douglas A. Kehring sold 35,000 shares of the company’s stock in a transaction dated Thursday, January 15th. The shares were sold at an average price of $194.89, for a total transaction of $6,821,150.00. Following the transaction, the executive vice president owned 33,638 shares in the company, valued at approximately $6,555,709.82. The trade was a 50.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 62,223 shares of company stock worth $12,136,764. Insiders own 40.90% of the company’s stock.

Analyst Upgrades and Downgrades

ORCL has been the subject of a number of recent research reports. The Goldman Sachs Group raised Oracle to a “strong-buy” rating in a report on Monday, January 12th. Oppenheimer reiterated a “market perform” rating on shares of Oracle in a research note on Thursday, December 11th. Evercore ISI lifted their price objective on Oracle from $350.00 to $385.00 and gave the company an “outperform” rating in a report on Friday, October 17th. UBS Group reaffirmed a “buy” rating on shares of Oracle in a report on Monday, January 5th. Finally, HSBC reissued a “buy” rating and set a $382.00 price target on shares of Oracle in a report on Wednesday, November 26th. Three research analysts have rated the stock with a Strong Buy rating, twenty-five have given a Buy rating, eleven have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, Oracle has an average rating of “Moderate Buy” and a consensus price target of $300.46.

Oracle Stock Down 1.2%

Shares of NYSE:ORCL opened at $172.89 on Thursday. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 3.28. The firm has a market cap of $496.72 billion, a P/E ratio of 32.50, a P/E/G ratio of 1.54 and a beta of 1.65. Oracle Corporation has a 12 month low of $118.86 and a 12 month high of $345.72. The company’s 50-day moving average price is $195.63 and its two-hundred day moving average price is $238.35.

Oracle (NYSE:ORCL) last announced its earnings results on Wednesday, December 10th. The enterprise software provider reported $2.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.64 by $0.62. The company had revenue of $16.06 billion for the quarter, compared to analyst estimates of $16.19 billion. Oracle had a net margin of 25.28% and a return on equity of 70.60%. Oracle’s quarterly revenue was up 14.2% on a year-over-year basis. During the same period in the prior year, the business earned $1.47 earnings per share. As a group, research analysts forecast that Oracle Corporation will post 5 EPS for the current fiscal year.

Oracle Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, January 23rd. Stockholders of record on Friday, January 9th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend was Friday, January 9th. Oracle’s dividend payout ratio (DPR) is 37.59%.

More Oracle News

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: AI infrastructure tailwind — coverage highlights Oracle’s high-performance computing cost advantage and market-share gains in AI infrastructure, supporting the long-term growth story. The AI Infrastructure Stock That’s Stealing Market Share in 2026
• Positive Sentiment: New business win — Alrajhi Medicine selected Oracle Health Foundation EHR and Fusion Cloud, a concrete enterprise win that supports recurring cloud/healthcare revenue expansion. Alrajhi Medicine to Digitize its Healthcare Operations with Oracle
• Positive Sentiment: CapEx ramp backing AI growth — Analysts note Oracle is ramping cloud CapEx toward ~$50B to build GPU-rich data centers aimed at accelerating revenue growth from FY2027 onward. This supports the long-term AI revenue thesis (but increases near-term financing needs). The Zacks Analyst Blog Oracle’s, Amazon and Alphabet
• Neutral Sentiment: Analyst/coverage attention — Zacks includes Oracle among names tied to AI and VMware integration in its research picks; supportive but not an immediate catalyst. The Zacks Analyst Blog Broadcom, Oracle, Mastercard, Geospace and Gencor
• Negative Sentiment: Operational outage — A weather-related power outage at an Oracle data center disrupted U.S. TikTok users, raising short-term reliability and reputational concerns (repeated coverage). Oracle says outage at data center causes issues faced by US TikTok users
• Negative Sentiment: Credit-market stress — Credit default swaps on Oracle have surged to levels not seen since the COVID era, signaling investor unease about the company’s rising debt load to fund cloud/GPU expansion. Chamath Palihapitiya’s Nervous ‘Gulp’ A Sign Of Things To Come? Oracle’s Credit Default Swaps Surge Past COVID-19 Levels
• Negative Sentiment: Legal/SEC risk — Multiple investor law firms (Rosen, Pomerantz) have filed/investigated class actions tied to Oracle’s senior note offering documents, adding legal exposure and headline risk. ORCL Investors Have Opportunity to Lead Oracle Corporation Securities Lawsuit
• Negative Sentiment: Analyst cut & execution concerns — At least one analyst sharply cut its price target and investor letters/notes (Polen) flagged execution risks, amplifying near-term selling pressure. Why 1 Analyst Just Slashed Their Price Target on Oracle Stock by More than 30%
• Negative Sentiment: Market reaction summary — Zacks notes the stock fell more than the market in the latest session, reflecting a combination of the above operational, credit and legal headlines. Here’s Why Oracle (ORCL) Fell More Than Broader Market

About Oracle

Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.

Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.